CF CARE Webinar Registration Form

Date: 18 September 2024

Time: 6.00‒7.30pm AEST (Sydney) | 9.00‒10.30am BST (London)*

*This webinar is available to health professionals from Europe, Australia and New Zealand. Please check session times for your local time zone. Due to pharmaceutical industry regulations, this webinar is for healthcare professionals and scientific professionals only, it is not open to patients or members of the public.

Venue: Online meeting (Zoom webinar)

"*" indicates required fields

Healthcare professional details

Healthcare professional confirmation*

Please provide your consent to the below privacy statement, then fill out the required information, and click Submit to continue. By registering, you’re confirming that you are a healthcare professional working in Cystic Fibrosis. This meeting is intended for healthcare professionals only.

I agree and understand that by submitting this form, the information I include will be processed by Vertex Pharmaceuticals (Australia) Pty Ltd, its global affiliates, and its service providers who provide services related to this meeting, in order to process my registration (including to facilitate and for record-keeping obligations), to comply with Vertex's legal obligations, for customer relationship management, and as further described in the Vertex Privacy Notice. Please do not include any health data in your registration. Please note, if you are in a country without legally required spend transparency reporting, Vertex's use of the information on this form for such purposes will depend on whether you have provided consent for such reporting as part of your contract for this meeting. Attendees are responsible for obtaining approval to receive and/or disclose hospitality as required by their employer or professional association.

Title*

First Name*

Last Name*

Email Address*

Country*

Organisation/institution

Profession*

Specialty*

Please list any questions you may have using the space below.

Questions will be anonymised, collated and directed to the panel.

Pre-Event Questions

Please help Vertex gauge the educational value of this event by completing this knowledge survey. The results will be compared to a similar survey completed after the event. All data will be anonymised before analysis. Note this is not an assessment; there are no right or wrong answers.

1. On a scale of 1 to 5, please rate how confident you are in broaching the topic of treatment adherence with people with CF and their families.*

(1=Not at all confident, 5=Extremely confident)

Please select12345

2. In your opinion, which of the following CF multidisciplinary team members should be actively involved in conversations about treatment adherence with patients and carers?*

(Select all that apply)

CF physicians

CF nurses

Psychologists

Physiotherapists

Dietitians

Other allied health practitioners

3. On a scale of 1 to 5, how familiar are you with Motivational Interviewing as a framework CF teams can use to identify factors that are impeding treatment adherence and compromising the ability of a person with CF to participate in and sustain daily care?*

(1=Not at all familiar, 5=Very familiar)

Please select12345

4. On a scale of 1 to 5, please rate your level of awareness of the CF CARE website and educational resources prior to registering for this webinar.*

(1=Limited awareness, 5=Strong awareness)

Please select12345

5. Have you previously used/accessed any of the tools or educational resources that are currently on the CF CARE website?*

Yes - I currently use tools and resources from the CF CARE website

I have used CF CARE tools and resources previously, but not recently/currently

No - I have not used CF CARE tools and resources before

NZ healthcare professionals need to be aware of the significant differences between Australia and New Zealand in terms of cystic fibrosis medication registration, availability and funding status. Please refer to the Medsafe and Pharmac websites for further information.

This CF CARE webinar is an educational programme organised by Vertex Pharmaceuticals (Australia) Pty Ltd and Vertex Pharmaceuticals (Europe) Limited (collectively – “Vertex”). All content is developed by the scientific committee and speakers, with support from a medical education agency acting as secretariat – all engaged by Vertex Pharmaceuticals (Australia) Pty Ltd on a fee-for-service basis. Vertex has had an opportunity to review the materials for scientific accuracy and fair balance.

Vertex complies with applicable privacy laws. Details of our privacy policy can be found at https://global.vrtx.com/internationalprivacy. You may access the information we hold about you by writing to the Privacy Office at privacy@vrtx.com.

Vertex and the Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated. Vertex Pharmaceuticals (Australia) Pty Ltd. ABN 34 160 157 157. Suite 3, Level 3, 601 Pacific Highway, St Leonards NSW 2065, Australia. New Zealand: Pharmacy Retailing (NZ) t/a Healthcare Logistics, P.O. Box 62027 Sylvia Park, Auckland 1644. Telephone: 0508 553 435 or email: vertexmedicalinfo@vrtx.com Vertex Medical Information contact: 1800 179 987 (AU) or 0508 553 435 (NZ). © 2024 Vertex Pharmaceuticals Incorporated. INT-20-2400054. Date of approval: May 2024. TAPS NP20604.